Lenalidomide is prescribed to treat multiple myeloma (bone marrow cancer), mantle cell lymphoma, myelodysplastic syndrome (MDS), and in multiple myeloma after a hematopoietic stem-cell transplant (HCST). Dose adjustment is required in kidney disease. It can pass into vomit, urine, feces, and caregivers should wear gloves.
All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.